In Kenya, Novo Nordisk tests a new business model to improve access to insulin

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
As part of an official Danish state visit to Kenya, Novo Nordisk on 12 April officially launched a programme to make insulin and diabetes care more accessible to poor populations.

In Kenya, 250,000 people are in need of insulin out of which 80,000 are people with an annual income between 1,500-3,000 US dollars. To make insulin more affordable and accessible to this group, Novo Nordisk has in partnership with local organisations and faith-based hospitals and clinics developed a new business model that includes a streamlined supply chain and treatment centres that are closer to the patients' homes.

The project has reduced price mark-ups in the supply chain to the extent that the insulin can be obtained at 20 cents daily, which is equivalent to a third of the previous price on the private market.

http://www.4-traders.com/NOVO-NORDI...del-to-improve-access-to-insulin-13-14270549/
 
Status
Not open for further replies.
Back
Top